Financhill
Back

Editas Medicine Stock Predictions

Editas Medicine Stock Forecast

  • Is Editas Medicine Stock Undervalued?
    The current Editas Medicine [EDIT] share price is $2.44. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Editas Medicine Stock Go Up Next Year?

Data Unavailable

Editas Medicine Stock Rating

Data Unavailable

Editas Medicine Stock Price History

Is EDIT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
editasmedicine.com

52-Week Data

52-Week High:
11.69
52-Week Low:
2.30

Prediction Charts

Market Cap:
201.42M
Price in USD:
2.44
Volume:
2.27M
Beta:
2.13

Technical Analysis

SMA50:
3.21
SMA100:
3.86
SMA200:
5.21
52-Wk Change:
-76.74%

Stock Predictions

  • Is Editas Medicine stock public?
    Yes, Editas Medicine is a publicly traded company.
  • What is the Editas Medicine stock quote today?
    The Editas Medicine stock price is 2.44 USD today.
  • How to buy Editas Medicine stock online?
    You can buy Editas Medicine shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 2.86 3.12 3.17 2.79
Nov-6 3.33 3.29 3.40 3.06
Nov-7 3.27 3.17 3.30 3.11
Nov-8 3.16 3.12 3.24 3.07
Nov-11 3.17 3.30 3.38 3.15
Nov-12 3.25 3.07 3.25 3.05
Nov-13 3.15 2.96 3.20 2.95
Nov-14 2.96 2.77 2.98 2.76
Nov-15 2.80 2.66 2.80 2.59
Nov-18 2.69 2.52 2.69 2.51
Nov-19 2.51 2.48 2.56 2.47
Nov-20 2.47 2.41 2.48 2.35
Nov-21 2.45 2.37 2.47 2.30
Nov-22 2.39 2.44 2.54 2.33

Editas Medicine Earnings

Data Unavailable

Editas Medicine Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.